by Eric Christianson | Jun 26, 2024 | Clinical Pharmacy News and New Drug Updates, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
by Eric Christianson | Mar 31, 2024 | Clinical Guideline Updates For Pharmacists
The Kidney Disease: Improving Global Outcomes (KDIGO) organization has released an updated April 2024 clinical practice guideline for the evaluation and management of Chronic Kidney Disease (CKD). The new 2024 KDIGO guidelines include 6 chapters dedicated to the...
by Eric Christianson | Feb 18, 2024 | Clinical Guideline Updates For Pharmacists, Endocrine Medication and Disease State Clinical Pearls
The 2024 ADA guidelines were released a month or two ago and I wanted to take a little time to digest them before providing my big takeaways. The 2023 guidelines saw a major shift in pharmacotherapy with a strong emphasis on compelling indications and recommended...
by Eric Christianson | Jan 8, 2023 | Clinical Guideline Updates For Pharmacists
The ADA has released its 2023 guidelines. There are a significant number of impacts on medication therapy, and in this post I will outline my most important takeaways. I was also recently catching up with my friend and fellow pharmacist, Derek Borkowski who is the...
by Eric Christianson | Dec 21, 2022 | Clinical Guideline Updates For Pharmacists
As the concerns surrounding opioid use have evolved, there have been more guidelines and organizations recommending guidance on prescribing practices of opioids. Today, we’ll be breaking down what you need to know from the 2022 CDC Opioid Guidelines’ recent...
